logo

NEO

Neogenomics·NASDAQ
--
--(--)
--
--(--)

NEO fundamentals

Neogenomics (NEO) expects to report earnings on Feb 17, 2026, with estimated revenue of 188.48M (YoY +9.58%), and EPS at 0.0382 (YoY -4.50%).
Revenue estimate / YoY
188.48M
+9.58%
EPS estimate / YoY
0.0382
-4.50%
Report date
Feb 17, 2026
Earnings Call
8:30 AM on Feb 17, 2026
Meeting link.
EPS
Revenue

Revenue & Expenses

NEO has released its 2025 Q3 earnings report, with revenue of 187.80M, reflecting a YoY change of 11.90%, and net profit of -27.13M, showing a YoY change of -53.28%. The Sankey diagram below clearly presents NEO's revenue sources and cost distribution.

Key Indicators

Neogenomics (NEO) key financial stats and ratios, covering profitability, financial health, and leverage.
Neogenomics (NEO)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Neogenomics (NEO)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Neogenomics (NEO)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Neogenomics (NEO) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Neogenomics (NEO) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield